Cargando…
Effect of short‐interval rituximab and high‐dose corticosteroids on kidney function in systemic sclerosis: Long‐term experience of a single centre
INTRODUCTION: Scleroderma renal crisis (SRC) is a rare but one of the most recognised complications of systemic sclerosis (SSc). Corticosteroid (CS) use has been considered as a major risk factor for SRC. Several studies reported the efficacy of rituximab (RTX) with an acceptable safety profile in S...
Autores principales: | Odler, Balazs, Hebesberger, Carina, Hoeflechner, Lukas, Pregartner, Gudrun, Gressenberger, Paul, Jud, Philipp, Zenz, Sabine, Eller, Kathrin, Rosenkranz, Alexander R., Moazedi‐Fuerst, Florentine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243981/ https://www.ncbi.nlm.nih.gov/pubmed/33540483 http://dx.doi.org/10.1111/ijcp.14069 |
Ejemplares similares
-
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis
por: Gressenberger, Paul, et al.
Publicado: (2021) -
The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis
por: Odler, Balazs, et al.
Publicado: (2021) -
Hypomagnesemia Is a Risk Factor for Infections after Kidney Transplantation: A Retrospective Cohort Analysis
por: Odler, Balazs, et al.
Publicado: (2021) -
Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases Results of a lower dosage and shorter interval regimen
por: Moazedi-Fuerst, FC, et al.
Publicado: (2014) -
Association of amino acids and parameters of bone metabolism with endothelial dysfunction and vasculopathic changes in limited systemic sclerosis
por: Jud, Philipp, et al.
Publicado: (2023)